Mifepristone 200 MG

DRUG5 trials

Conditions

AbortionBRCA1 MutationEndometrial Endocrine RegulationHigh-grade Serous Ovarian CancerPregnancy, UnwantedProgesterone Supplementation in Women After MifepristoneSecond Trimester AbortionTNBC - Triple-Negative Breast Cancer

Early Phase 1

Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone

CompletedNCT06616077

Reproductive Health Research Insritute, ChileEndometrial Endocrine Regulation, Progesterone Supplementation in Women After Mifepristone

Start: 2022-06-07End: 2023-05-08Updated: 2024-09-27

Phase 1

Blocking Mifepristone Action With Progesterone

TerminatedNCT03774745

University of California, DavisPregnancy, Unwanted

Start: 2019-02-11End: 2019-08-15Updated: 2020-01-22

Phase 2

Cervical Preparation With Mifepristone Prior to Osmotic Dilators

TerminatedNCT03714880

University of California, DavisSecond Trimester Abortion

Start: 2019-04-26End: 2021-02-26Updated: 2022-06-08

Unknown Phase

Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

CompletedNCT00986921

Boston UniversityAbortion

Start: 2009-10-31End: 2011-03-31Updated: 2014-01-31

Breast Cancer BRCA1 Carriers: a Pilot Study

WithdrawnNCT05062174

Indiana UniversityBRCA1 Mutation, High-grade Serous Ovarian Cancer, TNBC - Triple-Negative Breast Cancer

Start: 2021-11-01End: 2024-12-31Updated: 2022-12-15

Related Papers

Mifepristone Antagonization With Progesterone to Prevent Medical Abortion

Obstetrics and Gynecology2019-12-0345 citations